<?xml version="1.0" encoding="UTF-8"?>
<p>An issue that must be addressed is that BuChE has a more prominent role than AChE in elderly people and in more advanced stages of Alzheimer’s disease
 <xref rid="CIT0053" ref-type="bibr">
  <sup>53</sup>
 </xref>. Moreover, BuChE has also been reported to participate in amyloid plaques and neurofibrillary tangles-mediated neurodegeneration
 <xref rid="CIT0054" ref-type="bibr">
  <sup>54</sup>
 </xref>. This means that compounds 
 <bold>11e–g</bold> could be useful not only for re-establishing the cognitive functionality of the patients (by increasing the levels of cholinesterase) but also for retarding or ameliorating neurotoxicity associated with amyloidogenesis in advanced stages of the disease.
</p>
